The Mu-opioid receptor and the NMDA receptor associate in PAG neurons: Implications in pain control

Neuropsychopharmacology

Volumn 37, Issue 2, 2012, Pages 338-349

  Rodríguez Mũoz, María ^a   Sánchez Blázquez, Pilar ^a,b   Vicente Sánchez, Ana ^b   Berrocoso, Esther ^a,c   Garzón, Javier ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO CAJAL   (Spain)

^c UNIVERSITY OF CÁDIZ   (Spain)

Author keywords

analgesia; mu opioid receptor; N methyl D aspartate receptor; pain; periaqueductal gray; receptor association

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; GUANINE NUCLEOTIDE BINDING PROTEIN; MORPHINE; MU OPIATE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR 1; PROTEIN KINASE C; PROTEIN VARIANT;

ANALGESIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHO CELL; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; IMMUNOPRECIPITATION; MALE; MORPHINE TOLERANCE; MOUSE; NERVE CELL; NOCICEPTIVE STIMULATION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; POSTSYNAPTIC MEMBRANE; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RECEPTOR AFFINITY; RECEPTOR SOLUBILIZATION; SIGNAL TRANSDUCTION;

ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DRUG TOLERANCE; G-PROTEIN-COUPLED RECEPTOR KINASE 2; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MICE, INBRED ICR; MORPHINE; N-METHYLASPARTATE; NEURONS; PAIN; PERIAQUEDUCTAL GRAY; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTOR AGGREGATION; RECEPTORS, N-METHYL-D-ASPARTATE; RECEPTORS, OPIOID, MU;

EID: 84856063762     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.155     Document Type: Article

References (62)

1. Barbaro NM (1988). Studies of PAG/PVG stimulation for pain relief in humans. Prog Brain Res 77: 165-173.
2. Bilsky EJ, Inturrisi CE, Sadee W, Hruby VJ, Porreca F (1996). Competitive and non-competitive NMDA antagonists block the development of antinociceptive tolerance to morphine, but not to selective mu or delta opioid agonists in mice. Pain 68: 229-237. (Pubitemid 27025879)
3. Bird GC, Lash LL, Han JS, Zou X, Willis WD, Neugebauer V (2005). Protein kinase A-dependent enhanced NMDA receptor function in pain-related synaptic plasticity in rat amygdala neurones. J Physiol 564: 907-921. (Pubitemid 40704153)
4. Bittar RG, Kar-Purkayastha I, Owen SL, Bear RE, Green A, Wang S et al (2005). Deep brain stimulation for pain relief: a metaanalysis. J Clin Neurosci 12: 515-519. (Pubitemid 41044189)
5. Celerier E, Rivat C, Jun Y, Laulin JP, Larcher A, Reynier P et al (2000). Long-lasting hyperalgesia induced by fentanyl in rats: preventive effect of ketamine. Anesthesiology 92: 465-472. (Pubitemid 30078345)
6. 5]- enkephalinmu-opioid receptor complexes demonstrated by cyclic AMPdependent protein kinase phosphorylation. J Neurochem 71: 231-239. (Pubitemid 28292554)
7. 2+-calmodulin and protein kinase Cs: a hypothetical synthesis of their conflicting convergences on shared substrate domains. Trends Neurosci 22: 12-16. (Pubitemid 29130078)
8. Chapman V, Haley JE, Dickenson AH (1994). Electrophysiologic analysis of preemptive effects of spinal opioids on N-methyl-Daspartate receptor-mediated events. Anesthesiology 81: 1429-1435. (Pubitemid 24381435)
9. Chen L, Huang LY (1991). Sustained potentiation of NMDA receptor-mediated glutamate responses through activation of protein kinase C by a μ opioid. Neuron 7: 319-326.
10. Chetkovich DM, Sweatt JD (1993). NMDA receptor activation increases cyclic AMP in area CA1 of the hippocampus via calcium/calmodulin stimulation of adenylyl cyclase. J Neurochem 61: 1933-1942. (Pubitemid 23317222)
11. Commons KG, van Bockstaele EJ, Pfaff DW (1999). Frequent colocalization of mu opioid and NMDA-type glutamate receptors at postsynaptic sites in periaqueductal gray neurons. J Comp Neurol 408: 549-559. (Pubitemid 29211181)
12. Fiorentini C, Gardoni F, Spano P, Di LM, Missale C (2003). Regulation of dopamine D1 receptor trafficking and desensitization by oligomerization with glutamate N-methyl-D-aspartate receptors. J Biol Chem 278: 20196-20202. (Pubitemid 36799216)
13. Fu Y, Han J, Ishola T, Scerbo M, Adwanikar H, Ramsey C et al (2008). PKA and ERK, but not PKC, in the amygdala contribute to pain-related synaptic plasticity and behavior. Mol Pain 4: 26.
14. Garzón J, Rodríguez-Muñoz M, López-Fando A, Sánchez-Blázquez P (2005a). Activation of μ-opioid receptors transfers control of Ga subunits to the regulator of G-protein signaling RGS9-2: role in receptor desensitization. J Biol Chem 280: 8951-8960. (Pubitemid 40409587)
15. Garzón J, Rodriguez-Muñoz M, Sánchez-Blázquez P (2005b). Morphine alters the selective association between mu-opioid receptors and specific RGS proteins in mouse periaqueductal gray matter. Neuropharmacology 48: 853-868. (Pubitemid 40489041)
16. Garzón J, Rodriguez-Muñoz M, Sánchez-Blázquez P (2008). Do pharmacological approaches that prevent opioid tolerance target different elements in the same regulatory machinery? Curr Drug Abuse Rev 1: 222-238.
17. Garzón J, Rodríguez-Muñoz M, Vicente-Sánchez A, Bailón C, Martínez-Murillo R, Sánchez-Blázquez P (2011). RGSZ2 binds to the nNOS PDZ domain to regulate mu-opioid receptor-mediated potentiation of the NMDAR-CaMKII pathway. Antioxid Redox Signal 15: 873-887.
18. Glass MJ, Vanyo L, Quimson L, Pickel VM (2009). Ultrastructural relationship between N-methyl-D-aspartate-NR1 receptor subunit and mu-opioid receptor in the mouse central nucleus of the amygdala. Neuroscience 163: 857-867.
19. Gulya K, Krivan M, Nyolczas N, Sarnyai Z, Kovacs GL (1988). Central effects of the potent and highly selective mu opioid antagonist D-Phe-Cys-Tyr-D-Trp-Orn-Thr-Pen-Thr-NH2 (CTOP) in mice. Eur J Pharmacol 150: 355-360.
20. Hisatsune C, Umemori H, Inoue T, Michikawa T, Kohda K, Mikoshiba K et al (1997). Phosphorylation-dependent regulation of N-methyl-D-aspartate receptors by calmodulin. J Biol Chem 272: 20805-20810. (Pubitemid 27355649)
21. Hull LC, Llorente J, Gabra BH, Smith FL, Kelly E, Bailey C et al (2010). The effect of protein kinase C and G protein-coupled receptor kinase inhibition on tolerance induced by mu-opioid agonists of different efficacy. J Pharmacol Exp Ther 332: 1127-1135.
22. Inoue M, Mishina M, Ueda H (2003). Locus-specific rescue of GluRe1 NMDA receptors in mutant mice identifies the brain regions important for morphine tolerance and dependence. J Neurosci 23: 6529-6536. (Pubitemid 36909879)
23. Kornau HC, Schenker LT, Kennedy MB, Seeburg PH (1995). Domain interaction between NMDA receptor subunits and the postsynaptic density protein PSD-95. Science 269: 1737-1740.
24. Kow LM, Commons KG, Ogawa S, Pfaff DW (2002). Potentiation of the excitatory action of NMDA in ventrolateral periaqueductal gray by the mu-opioid receptor agonist, DAMGO. Brain Res 935: 87-102. (Pubitemid 34327849)
25. Koyama S, Akaike N (2008). Activation of mu-opioid receptor selectively potentiates NMDA-induced outward currents in rat locus coeruleus neurons. Neurosci Res 60: 22-28.
26. Lipton SA (2006). Paradigm shift in neuroprotection by NMDA receptor blockade: memantine and beyond. Nat Rev Drug Discov 5: 160-170.
27. Lu WY, Xiong ZG, Lei S, Orser BA, Dudek E, Browning MD et al (1999). G-protein-coupled receptors act via protein kinase C and Src to regulate NMDA receptors. Nat Neurosci 2: 331-338. (Pubitemid 30491275)
28. Maeng S, Zarate Jr CA (2007). The role of glutamate in mood disorders: results from the ketamine in major depression study and the presumed cellular mechanism underlying its antidepressant effects. Curr Psychiatry Rep 9: 467-474. (Pubitemid 350284937)
29. Malleret G, Haditsch U, Genoux D, Jones MW, Bliss TV, Vanhoose AM et al (2001). Inducible and reversible enhancement of learning, memory, and long-term potentiation by genetic inhibition of calcineurin. Cell 104: 675-686. (Pubitemid 32241018)
30. Mansour A, Khachaturian H, Lewis ME, Akil H, Watson SJ (1988). Anatomy of CNS opioid receptors. Trends Neurosci 11: 308-314.
31. Marinelli S, Vaughan CW, Schnell SA, Wessendorf MW, Christie MJ (2002). Rostral ventromedial medulla neurons that project to the spinal cord express multiple opioid receptor phenotypes. J Neurosci 22: 10847-10855. (Pubitemid 36005159)
32. Martin G, Nie Z, Siggins GR (1997). mu-Opioid receptors modulate NMDA receptor-mediated responses in nucleus accumbens neurons. J Neurosci 17: 11-22. (Pubitemid 27008846)
33. Mechri A, Saoud M, Khiari G, d'Amato T, Dalery J, Gaha L (2001). Glutaminergic hypothesis of schizophrenia: clinical research studies with ketamine. Encephale 27: 53-59. (Pubitemid 32234479)
34. Mizoguchi H, Watanabe C, Yonezawa A, Sakurada S (2009). New therapy for neuropathic pain. Int Rev Neurobiol 85: 249-260.
35. Mori H, Mishina M (1995). Structure and function of the NMDA receptor channel. Neuropharmacology 34: 1219-1237.
36. Narita M, Hashimoto K, Amano T, Narita M, Niikura K, Nakamura A et al (2008). Post-synaptic action of morphine on glutamatergic neuronal transmission related to the descending antinociceptive pathway in the rat thalamus. J Neurochem 104: 469-478. (Pubitemid 350293886)
37. Olverman HJ, Jones AW, Watkins JC (1984). L-glutamate has higher affinity than other amino acids for [3H]-D-AP5 binding sites in rat brain membranes. Nature 307: 460-462. (Pubitemid 14132061)
38. Owen SL, Green AL, Nandi DD, Bittar RG, Wang S, Aziz TZ (2007). Deep brain stimulation for neuropathic pain. Acta Neurochir Suppl 97: 111-116.
39. Palmer GC (2001). Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies. Curr Drug Targets 2: 241-271. (Pubitemid 32821469)
40. Pan YX (2005). Diversity and complexity of the mu opioid receptor gene: alternative pre-mRNA splicing and promoters. DNA Cell Biol 24: 736-750.
41. Pei L, Lee FJ, Moszczynska A, Vukusic B, Liu F (2004). Regulation of dopamine D1 receptor function by physical interaction with the NMDA receptors. J Neurosci 24: 1149-1158. (Pubitemid 38177022)
42. Perroy J, Raynaud F, Homburger V, Rousset MC, Telley L, Bockaert J et al (2008). Direct interaction enables cross-talk between ionotropic and group I metabotropic glutamate receptors. J Biol Chem 283: 6799-6805.
43. Przewlocki R, Parsons KL, Sweeney DD, Trotter C, Netzeband JG, Siggins GR et al (1999). Opioid enhancement of calcium oscillations and burst events involving NMDA receptors and L-type calcium channels in cultured hippocampal neurons. J Neurosci 19: 9705-9715. (Pubitemid 30226644)
44. Redwine KE, Trujillo KA (2003). Effects of NMDA receptor antagonists on acute mu-opioid analgesia in the rat. Pharmacol Biochem Behav 76: 361-372. (Pubitemid 37336559)
45. Rodríguez-Muñoz M, de la Torre-Madrid E, Gaitán G, Sánchez-Blázquez P, Garzón J (2007a). RGS14 prevents morphine from internalizing mu-opioid receptors in periaqueductal gray neurons. Cell Signal 19: 2558-2571. (Pubitemid 47531935)
46. Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Garzón J (2007b). Morphine induces endocytosis of neuronal mu-opioid receptors through the sustained transfer of Galpha subunits to RGSZ2 proteins. Mol Pain 3: 19.
47. Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Garzón J (2011a). NO-released zinc supports the simultaneous binding of Raf-1 and PKCg cysteine-rich domains to HINT1 protein at the mu-opioid receptor. Antioxid Redox Signal 14: 2413-2425.
48. Rodríguez-Muñoz M, de la Torre-Madrid E, Sánchez-Blázquez P, Wang JB, Garzón J (2008). NMDAR-nNOS generated zinc recruits PKCg to the HINT1-RGS17 complex bound to the C terminus of mu-opioid receptors. Cell Signal 20: 1855-1864.
49. Rodríguez-Muñoz M, Sánchez-Blázquez P, Vicente-Sánchez A, Bailón C, Martín-Aznar B, Garzón J (2011b). The histidine triad nucleotide-binding protein 1 supports mu-opioid receptor-glutamate NMDA receptor cross-regulation. Cell Mol Life Sci; doi:10.1007/s00018-010-0598-x.
50. Rusin KI, Randic M (1991). Modulation of NMDA-induced currents by mu-opioid receptor agonist DAGO in acutely isolated rat spinal dorsal horn neurons. Neurosci Lett 124: 208-212.
51. Sánchez-Blázquez P, Rodríguez-Muñoz M, de la Torre-Madrid E, Garzón J (2009). Brain-specific Gaz interacts with Src tyrosine kinase to regulate mu-opioid receptor-NMDAR signaling pathway. Cell Signal 21: 1444-1454.
52. Sánchez-Blázquez P, Rodríguez-Muñoz M, Garzón J (2010). Muopioid receptors transiently activate the Akt-nNOS pathway to produce sustained potentiation of PKC-mediated NMDAR-CaMKII signaling. PLoS One 5: e11278.
53. Sánchez-Blázquez P, Rodríguez-Muñoz M, Montero C, de la Torre-Madrid E, Garzón J (2008). Calcium/calmodulin-dependent protein kinase II supports morphine antinociceptive tolerance by phosphorylation of glycosylated phosducin-like protein. Neuropharmacology 54: 319-330.
54. Saper CB, Sawchenko PE (2003). Magic peptides, magic antibodies: guidelines for appropriate controls for immunohistochemistry. J Comp Neurol 465: 161-163. (Pubitemid 37100126)
55. Shyu YJ, Hiatt SM, Duren HM, Ellis RE, Kerppola TK, Hu CD (2008). Visualization of protein interactions in living Caenorhabditis elegans using bimolecular fluorescence complementation analysis. Nat Protoc 3: 588-596. (Pubitemid 351516754)
56. Sigtermans MJ, van Hilten JJ, Bauer MC, Arbous MS, Marinus J, Sarton EY et al (2009). Ketamine produces effective and longterm pain relief in patients with Complex Regional Pain Syndrome Type 1. Pain 145: 304-311.
57. Tingley WG, Ehlers MD, Kameyama K, Doherty C, Ptak JB, Riley CT et al (1997). Characterization of protein kinase A and protein kinase C phosphorylation of the N-methyl-D-aspartate receptor NR1 subunit using phosphorylation site-specific antibodies. J Biol Chem 272: 5157-5166. (Pubitemid 27090073)
58. Trujillo KA (2002). The neurobiology of opiate tolerance, dependence and sensitization: mechanisms of NMDA receptordependent synaptic plasticity. Neurotox Res 4: 373-391.
59. Westphal RS, Tavalin SJ, Lin JW, Alto NM, Fraser ID, Langeberg LK et al (1999). Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 285: 93-96. (Pubitemid 29307572)
60. Wong EH, Kemp JA, Priestley T, Knight AR, Woodruff GN, Iversen LL (1986). The anticonvulsant MK-801 is a potent N-methyl-Daspartate antagonist. Proc Natl Acad Sci USA 83: 7104-7108. (Pubitemid 16002378)
61. Zalewski PD, Forbes IJ, Giannakis C, Cowled PA, Betts WH (1990). Synergy between zinc and phorbol ester in translocation of protein kinase C to cytoskeleton. FEBS Lett 273: 131-134. (Pubitemid 20362449)
62. Zukin RS, Bennett MV (1995). Alternatively spliced isoforms of the NMDARI receptor subunit. Trends Neurosci 18: 306-313.